Demonstration of C-peptide immunoreactivity in various body fluids and clinical evaluation of the determination of urinary C-peptide immunoreactivity.
C-peptide immunoreactivity (CPR) was demonstrated not only in plasma, but in urine, ascites, cerebrospinal fluid and pleural effusion. The concentration of  CPR in urine was very high compared with that in the other body fluids and was easy to assay. CPR in urine after glucose administration or tolbutamide injection increased parallel to the change of CPR in plasma and also to that of IRI in normals or diabetics without renal disturbances. The result suggest that the determination of CPR in urine before and after stimulation of insulin secretion could serve as a simple indicator of insulin secretory function of pancreas.
D000328:Adult; D000941:Antigens / Q000032:analysis*; D001202:Ascitic Fluid / Q000032:analysis; D003920:Diabetes Mellitus / Q000652:urine*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000032:analysis* / Q000097:blood / Q000134:cerebrospinal fluid / Q000652:urine; D010996:Pleural Effusion / Q000032:analysis
D000941:Antigens; D010455:Peptides